Showing results (141-150 of 835) with videos related to
Sort By:
Pageof 84
Talanta|May 1, 2024
A simple and highly sensitive flexible sensor with extended-gate field-effect transistor for epinephrine detection utilizing InZnSnO sensing filmsTung-Ming Pan, Li-An Lin, Hong-Yan Ding, et al.Journal of the American College of Cardiology|November 21, 2009
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)L Julian Haywood, Charles E Ford, Richard S Crow, et al.Journal of Hypertension|January 25, 2020
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialStephen P Juraschek, Lara M Simpson, Barry R Davis, et al.Pharmacogenetics and Genomics|March 6, 2012
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT studyAmy I Lynch, John H Eckfeldt, Barry R Davis, et al.Clinical Trials (London, England)|November 11, 2005
The Society for Clinical Trials supports United States legislation mandating trials registration. Position paperKay Dickersin, Barry R Davis, Dennis O Dixon, et al.Annals of Internal Medicine|June 9, 2016
Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial ExecutionBryan R Luce, Jason T Connor, Kristine R Broglio, et al.JAMA|January 24, 2008
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertensionAmy I Lynch, Eric Boerwinkle, Barry R Davis, et al.Pharmacogenetics and Genomics|April 9, 2009
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT studyAmy I Lynch, Eric Boerwinkle, Barry R Davis, et al.Oncotargets and Therapy|May 7, 2015
Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2Ping Zhang, He-Sheng Luo, Ming Li, et al.Zhonghua Nei Ke Za Zhi|January 16, 2007
[The effect and mechanism of cholecystokinin octapeptide induced-gastric dysmotility on bile regurgitation during stress]Xin-min Si, Lei Huang, He-sheng Luo, et al.Pageof 84